These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 544494)

  • 1. Genital mycoplasma in intrauterine contraceptive device users.
    Gupta I; Sharma S; Ganguli NK; Devi PK
    Indian J Pathol Microbiol; 1979 Jul; 22(3):235-8. PubMed ID: 544494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
    Mehanna MT; Rizk MA; Ramadan M; Schachter J
    Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contraception and cervical colonization with mycoplasmas and infection with cytomegalovirus.
    Gump DW; Horton EL; Phillips CA; Mead PB; Forsyth BR
    Fertil Steril; 1975 Nov; 26(11):1135-9. PubMed ID: 171177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemic investigation of genital mycoplasma hominis infection in women].
    Li H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Apr; 13(2):82-4. PubMed ID: 1394388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic adhesions in intrauterine device users.
    Kirshon B; Poindexter AN; Spitz MR
    Obstet Gynecol; 1988 Feb; 71(2):251-4. PubMed ID: 3336560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of the progesterone T intrauterine device].
    Pizarro Orchard E; Gómez Rogers C
    Rev Chil Obstet Ginecol; 1980; 45(2):87-98. PubMed ID: 6765370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study.
    Avonts D; Sercu M; Heyerick P; Vandermeeren I; Meheus A; Piot P
    Sex Transm Dis; 1990; 17(1):23-9. PubMed ID: 2305333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of genital tract infection with Entamoeba gingivalis among copper T 380A intrauterine device users in Egypt.
    Foda AA; El-Malky MM
    Contraception; 2012 Jan; 85(1):108-12. PubMed ID: 22067807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the effectiveness of the Lippes Loop, the Copper-T-200, and the Nova-T intrauterine contraceptive devices in Lagos, Nigeria.
    Oyediran MA; Akinla OA; Aderinola EA
    Int J Fertil; 1982; 27(2):109-12. PubMed ID: 6126444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine devices.
    Burkman RT
    Curr Opin Obstet Gynecol; 1991 Aug; 3(4):482-5. PubMed ID: 1878504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of actinomycetes infection in women using intrauterine contraceptive devices.
    Nayar M; Chandra M; Chitraratha K; Kumari Das S; Rai Chowdhary G
    Acta Cytol; 1985; 29(2):111-6. PubMed ID: 3856980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
    Larsson B; Rodau S; Patek E
    Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual bleeding pattern and iron status in women fitted with copper and non-medicated intrauterine contraceptive devices.
    Oyelola OO; Okonofua FE; Adediran TO
    East Afr Med J; 1994 Apr; 71(4):268-70. PubMed ID: 8062778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal pH effects caused by OCs and various copper and inert IUDs.
    Kandil O; Hassanein MK; El-tagi A; El-shirbini MT
    Contracept Deliv Syst; 1983 Jul; 4(3):187-93. PubMed ID: 12265361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New studies link IUDs, infertility; say copper devices safer.
    Contracept Technol Update; 1985 Jun; 6(6):81-3. PubMed ID: 12313655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?
    Neale R; Knight I; Keane F
    Int J STD AIDS; 2009 Jun; 20(6):423-4. PubMed ID: 19451330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hysteroscopic assessment of abnormal uterine bleeding in users of the intrauterine contraceptive device.
    Kulkarni S; Wynter HH; Desai P
    West Indian Med J; 1993 Sep; 42(3):124-5. PubMed ID: 8273322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.